Article Text

Download PDFPDF
Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease
  1. Qi-feng Liu1,
  2. Jian-ming Ye1,
  3. Li-xia Yu1,
  4. Ao-lin He2,
  5. Qiang Sun1,
  6. Da-wei He2,
  7. Sha-sha Li2
  1. 1 Department of Nephrology, Kunshan First People’s Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, China
  2. 2 Clinical and Lab Research Centre, Kunshan First People’s Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, China
  1. Correspondence to Dr Sha-sha Li, Clinical & Lab Research Centre, Kunshan First People’s Hospital, Affiliated to Jiangsu University, Kunshan 215300, Jiangsu, China; whitelss{at}


To investigate whether the soluble Klotho (s-Klotho) level in patients with chronic kidney disease (CKD) is related to kidney function and whether a low s-Klotho level can predict adverse renal outcomes or CKD progression in patients with advanced CKD. 112 patients with CKD stages 3–5 and 30 healthy volunteers were enrolled. Blood samples were collected to measure serum creatinine, calcium, phosphorus, intact parathyroid hormone, and hemoglobin. s-Klotho and fibroblast growth factor 23 (FGF23) were determined by ELISA. We first conducted a cross-sectional study to investigate correlations between s-Klotho and estimated glomerular filtration rate (eGFR) and other parameters. Patients were then followed prospectively for 20.1±10.1 months according to s-Klotho median level until serum creatinine doubled, or initiation of renal replacement therapy, or death. s-Klotho levels inpatients with CKD were significantly lower than that in the control group. For patients with CKD, there were no differences in age distribution among subgroups. However, s-Klotho level differed significantly across CKD stages, and it was lower in the advanced CKD group compared with the moderate CKD group. Correlation analysis revealed that s-Klotho was positively associated with eGFR, but inversely associated with FGF23. During the follow-up of 20.1±10.1 months, patients with higher s-Klotho levels showed a reduced risk of kidney adverse outcomes, including serum creatinine doubling and initiation of renal replacement therapy. Cox regression analysis revealed that low s-Klotho was an independent risk factor for CKD progression. s-Klotho level was closely correlated with kidney function, further, low s-Klotho level could predict adverse kidney disease outcomes in patients with progressive CKD.

  • kidney diseases
  • kidney failure
  • chronic

Statistics from


  • Contributors Methodology: QL, JMY, LY. Project administration: AH, QS, DH, SL. Writing—original draft and editing: QL, SL.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval The ethics committee of Kunshan First People’s Hospital Affiliated to Jiangsu University, China, and was performed in accordance with the principles contained within the Declaration of Helsinki.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.